Outcome of Board Meeting

September 03, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Outcome of Board Meeting held on Thursday, September 03, 2026 Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject; we, M/s Zota Health Care Limited (the “Company”) would like to inform you that the Board of Directors of the Company in its meeting held on Thursday, September 03, 2026 at 02:00 P.M. have, inter alia, discussed and approved following businesses: 1. Considered and Approved the Director’s Report for the year ended March 31, 2026. 2. Considered and approved Notice of the 26th Annual General Meeting (AGM). Board has decided to hold the 26th AGM on Monday, September 28, 2026 at 11:00 A.M. through Video Conferencing (VC) or Other Audio Visual Means (OAVM). Notice of the 26th AGM of the Company is enclosed herewith (Annexure – 2). 3. Decided Monday, September 21, 2026 as the Record date as for the purpose of E-voting and payment of final Dividend. Dividend shall be payable to Equity Shareholders, whose names stand registered on the Company’s Register of Members: a) As Beneficial Owners as at the end of business hours on September 21, 2026 as per the list provided by National Securities Depository Limited and Central Depository Services (India) Limited in respect of the shares held in the electronic form and; b) As Members in the Register of Members of the Company after giving effect to valid deletion of name /transmission (As per SEBI circular, as of now no physical transfer of shares are permitted) in physical form lodged with the Company before September 21, 2026. Member’s whose names are appearing on register of members as on September 21, 2026 shall be eligible for e-voting. 4. The Board has appointed Mr. Ranjit Binod Kejriwal, Practicing Company Secretary, as the Scrutinizer to scrutinize the remote e-voting process and the votes casted through e-voting system during the 26th AGM of the Company. The e-voting facility shall start from Friday, September 25, 2026 at 9:00 A.M. and shall end on Sunday, September 27, 2026 on 5:00 P.M. Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 5. Considered and approved the appointment of Mr. Mahaveer Dhariwal (DIN: 11893880), as the Additional Director, to be designated as the Independent Director of the Company, subject to the approval of the shareholders at the ensuing AGM, who shall hold office for the period of five consecutive years commencing from September 03, 2026 to September 02, 2031 on such terms and conditions as determined by the Board from time and time. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are annexed herewith as Annexure-1. The Board meeting concluded at 6:15 P.M. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Annexure-1 Particulars Details Name of Director Mr. Mahaveer Dhariwal (DIN: 11893880) Reason for change viz. Appointed as the Additional Director, to be designated as the appointment, resignation, Independent Director of the Company. removal, death or otherwise Date of appointment For the period of five consecutive years commencing from /cessation/reappointment September 03, 2026 to September 02, 2031; subject to the approval (as applicable) & term of of the shareholders at the ensuing Annual General Meeting. appointment Brief profile (in case of CA Mahaveer Dhariwal is a Chartered Accountant with over 15 years appointment) of experience. He has worked with ICICI Bank, where he gained deep hands-on experience in banking operations, treasury forex functions and financial processes. He is also well-versed in handling tax disputes, tax litigation and international taxation matters. Beyond traditional finance, he uses modern technical tools to automate data and processes, helping people get clear and timely information to make better business decisions. Many leading banks and financial institutions have recognized and awarded him for his outstanding work offered in the area of business finance. Disclosure of Relationship N.A. between Directors (in case of appointment of a director) Information as required Mr. Mahaveer Dhariwal is not debarred from holding the office of under applicable SEBI Director by virtue of any order passed by the Securities and Circulars Exchange Board of India or any other statutory authority. ANNEXURE-2 NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given for the 26th Annual General Meeting of the members of M/s Zota Health Care Limited (the “Company”) will be held on Monday, the 28th day of September, 2026 at 11.00 A.M. through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), to transact the following businesses: The Venue of the meeting shall be deemed to be the registered office of the Company situated at Zota House, 2/896, Hira Modi Street, Sagrampura, Surat – 395002, Gujarat, India. ORDINARY BUSINESSES: 1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended on March 31, 2026, together with the Reports of the Board of Directors and Auditors thereon. 2. Declaration of final dividend on equity shares @ 10% i.e. Re. 1/- per equity share for FY 2025-26. 3. To appoint the Director in place of Mr. Kamlesh Rajanikant Zota (DIN: 00822705), Whole-time Director of the Company, who shall retire by rotation in terms with Section 152(6) of the Companies Act, 2013 and being eligible, seeks re-appointment. SPECIAL BUSINESSES: 4.To appoint Mr. Mahaveer Dhariwal (DIN: 11893880) as the Independent Director of the Company To consider and if through fit, to pass with or without modification, the following resolution as the Special Resolution: “RESOLVED THAT pursuant to the provisions of Section 149 and 152 read with Schedule IV of the Companies Act, 2013 (“the Act”) and the Companies (Appointment and Qualification of Directors) Rules, 2014, any other applicable provisions, Regulation 17(6)(e) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), any other applicable regulations (including any statutory modification(s) or re-enactment thereof for the time being in force) and any other applicable laws, if any, pursuant to recommendation of the Nomination and Remuneration Committee and the Board of Directors of the Company; the consent of the members of the Company, be and are hereby accorded to appoint Mr. Mahaveer Dhariwal (DIN: 11893880), who was appointed as the Additional Director designated as the Independent Director on the Board of Directors of the Company w.e.f. September 03, 2026, in terms of Section 161 of the Act and who holds office up to the date of this ensuing Annual General Meeting (“AGM”); be and is hereby appointed as the Independent Director of the Company for a term of five consecutive years commencing from September 03, 2026 to September 02, 2031 at following terms and conditions: (1) Period of appointment: Appointment for a term of five consecutive years commencing from September 03, 2026 to September 02, 2031; (2) Remuneration: NIL; (3) Sitting Fees: Rs. 10,000/- per meeting for attending meeting of the Board or Committees thereof.” “RESOLVED FURTHER THAT the Board of Directors of the Company, be and are hereby authorised to do all acts and to take all such steps as may be necessary, proper or expedient to give effect to this reso [Showing first 8,000 characters — download PDF for full document]